Services
Interventional radiology
Our role Interventional radiology is a set of techniques that are minimally invasive and use medical imaging to visualise, access and act on an organ for the purposes of diagnosis and/or treatment. Image Image Image We use ultrasound, angiography, scanners and sometimes MRI to carry out biopsies or ablations, place a stent or inject a treatment. In principle, this is possible for all the systems and most of the organs of the human body. Dr Fadi Tannouri Head of the Interhospital Department of Interventional Radiology at the H.U.B Our specialities The H.U.B’s Interhospital Department of Interventional Radiology is divided into 5 sections:   Vascular disease and embolization covers arterial or venous angiography and angioplasty (placing of a stent and prosthesis, in cooperation with  vascular surgery) and embolization. The latter consists of blocking a blood vessel for therapeutic purposes, to stop haemorrhaging for example.   The osteoarticular  section covers infiltrations, biopsies, the thermoablation of bone tumours and cementoplasty (injection of intraosseous “cement”) with or without percutaneous osteosynthesis, in cooperation with orthopaedic surgery. The nephrology, urology and gynaecology  sector covers the embolization of uterine fibroids, of benign  prostatic hypertrophy and of pelvic  varicoceles and varicose veins, as well as nephrostomy. This section also provides vascular access for dialysis and creates arteriovenous fistula by percutaneous means.  The oncological section permits the placing of implantable ports and PICC lines (venous access),  pain management through infiltration, neuroloysis or radiofrequency as well as the treatment of certain cancers (see Focus).   The thoracic pathologies section covers biopsies, haemostatic embolization, percutaneous ablation of lung tumours and thermoablation of benign thyroid nodules.    Interventional radiology also covers biopsies and drainage under ultrasound, radiological or tomodensitomety (scanner) control.     Our team Image Our specialists Focus Interventional radiology is used for a minimally invasive treatment of certain cancers and benign tumours. A number of techniques are proposed:   The destruction of liver, kidney and lung tumours by thermoablation (radiofrequencies, microwaves and cryotherapy);   Chemoembolization, radioembolization and portal embolization;    Thermoablation of benign thyroid nodules ; Embolization of prostatic arteries in the framework of benign hypertrophy of the prostate gland.    Forward-looking studies Percutaneous AVF creation outcome and complications Prostate artery embolization: comparing embolic material Varicocele embolization: comparing embolic material
Radiologie Interventionnelle Vasculaire Et Générale - Erasme
Health issues
Rare and complex epilepsies
Description Epilepsy is a chronic neurological disease. It is common, can first appear at any age and covers a very heterogeneous group of diseases with multiple causes. In one third of cases epileptic seizures continue despite medication (refractory epilepsy).  A considerable number of patients present a rare and distinct epileptic syndrome for which the prognosis for controlling the seizures and neurological development is poor. These rare epilepsies are for the most part of genetic origin. Rare and complex epilepsies affect almost 5 persons in every 10,000 of the population.  Treatment The Epileptology Clinic of the Erasmus Hospital and Queen Fabiola Children’s University Hospital (HUDERF) possesses specific expertise in treating complex epilepsies.  The centre is recognised by the INAMI/RIZIV [Belgian National Institute for Health and Disability Insurance] as an approved Belgian centre for the treatment of refractory epilepsies.  The rooms at our Epilepsy Exploration Unit ere specially equipped for prolonged video EEG monitoring. The Erasmus Hospital is specialised in intracranial EEG monitoring for the pre-surgery assessment of refractory epilepsies while the HUDERF is specialised in treating epilepsy in children. The multidisciplinary approach at the two sites permits a full range of diagnostic and treatment methods, from the latest medicines and ketogenic diet to surgery.   The H.U.B’s Rare Diseases Function provides access to leading edge  genetic diagnostic technologies that make it possible to identify a genetic cause in a large number of patients with rare and complex  epilepsies and thereby permit targeted treatment. Thanks to close cooperation with neuropaediatrics at the Erasmus Hospital and the HUDERF we are able to offer paediatric patients a structured transition to care in adulthood that is adapted specifically to the individual needs of each patient. Our multidisciplinary medical and paramedical care allows us to treat not only epilepsy but also the medical conditions that are often associated with epilepsy. Advice Genetic factors play an important role in epilepsy, especially if the epilepsy first appears in childhood or is associated with developmental disorders.  Specialised genetic testing is then indicated. Several hundred genes are associated with epilepsy. Identifying a genetic cause not only permits a precise diagnosis but also genetic advice, the prognosis and – increasingly frequently – precision treatment. For patients with refractory epilepsy, pre-surgery exploration can lead to a surgical solution (brain surgery, gamma knife, vagus nerve stimulation, deep brain stimulation, Laser Interstitial Thermal Therapy (LITT). Research Other areas of expertise and research activities:Prolonged EEG monitoring at the Intensive Care Unit to diagnose epileptic seizures in seriously ill patientsParticipation in pharmaceutical trials sponsored by the industry on the use of the latest drugsParticipation in research and expertise networks:Epinord (Franco-Belgian intracranial ’EEG expertise group)ERN EpiCARE (European Reference Network for Rare and Complex Epilepsies)The genetic research networks EpiGen, Epi25 and Consortium on Complex Epilepsies of the International League Against Epilepsy (ILAE)Critical Care EEG Monitoring Research Consortium(CCEMRC)  Documents and useful links Epileptology Clinic HUDERF Department of NeuropaediatricsEpilepsy Exploration UnitERN EpiCARE (European Reference Network for Rare and Complex Epilepsies)Epi25 NetworkConsortium on Complex Epilepsies of the International League Against Epilepsy (ILAE)Critical Care EEG Monitoring Research Consortium (CCEMRC)Patients’ associations: https://ligueepilepsie.behttps://www.epilepsieliga.be Our specialists Neurologists specialising in epilepsy: Prof. Chantal Depondt (Head of the Rare Neurological Diseases Clinic)Prof. Nicolas Gaspard (Head of the Department of Neurology)Dr. Benjamin Legros (Head of the Adult Epileptology Clinic and of the Reference Centre for the treatment of Refractory Epilepsy)Paediatricians specialising in epilepsy: Prof. Alec Aeby (Head of the Department of Neuropaediatrics)Dr. Tom Balfroid (Erasmus Hospital)Dr. Cynthia Prigogine (HUDERF)Dr. Claudine Sculier (Erasmus Hospital – Medical consultant at the Epilepsy Exploration Unit)Dr. Pauline Van Gyseghem (HUDERF)
Rare and complex epilepsies
Health issues
Rare diseases
Rare diseases function Patients with a rare disease must receive proper and specific care: a rapid diagnosis followed by treatment in care units with staff trained in these rare diseases. The mission of the Rare Diseases Function (8 in Belgium) is to coordinate, with teams with the required expertise, the care pathways and scientific research and training projects of all the professionals involved  in providing an adapted and constantly evolving care.  
Rare diseases
Article
Rare diseases: 8 questions to ask
Did you know that 8 questions asked to your patients can already guide you in the case of a rare disease? If you can answer most of these 8 questions with 'yes' and your intuition confirms it, it would be wise to consider a rare disease. Does the patient present with acute or chronic symptoms that are inexplicable, inconsistent or non-specific, or symptoms at an unusually young age? Is there a family history? Have there been a number of periods of illness with different or identical symptoms? Is there a history of consultations with different medical specialities without satisfactory results? Are there any pathological or borderline results that are inconclusive at first sight? Has there ever been any suspicion of psychosomatic aetiology? Have there been phases of the illness going back several years? Are certain exposure scenarios known (in relation to food, leisure activities, housing, animals, travel or work)? Do not hesitate to refer your patient to a health specialist or geneticist, preferably linked to one of our designated centres of expertise for rare diseases, who are better placed to make a diagnosis.  For more information, visit https://ulbgenetics.be/fonctions-maladies-rares/ * These 8 questions were written by rare disease experts involved in the EMRaDi project.
Health issues
Raynaud’s disease
What is Raynaud’s disease? Raynaud’s disease is a disorder that affects the blood circulation, principally in the fingers and toes but sometimes in the ears, nipples, knees or nose.  It is characterised by a vasospasm – sudden constrictions of the blood vessels that considerably reduce the blood flow to the extremities – most often triggered by an exposure to cold but also by emotional stress. It can exist as an isolated  condition (primary Raynaud’s disease), in which case it is observed more frequently in women and people living in colder climates. The exact cause of primary Raynaud’s disease is not known.      Raynaud’s disease also occurs in men and women with autoimmune diseases, diseases of the conjunctive tissue and also other diseases, most notably:  Systemic scleroderma  Disseminated lupus erythematosis Sjögren’s disease  Rheumatoid polyarthritis  Polymyositis  Pulmonary hypertension Buerger’s disease (thromboangiitis obliterans) In these cases one speaks of secondary Raynaud’s disease. What are the risk factors?  Although we don’t know why certain persons develop Raynaud’s disease, certain risk factors are known:  Pre-existing connective tissue Autoimmune disease Smoking Repetitive pressure exercised on the hands, by using vibrating tools for example (electric tools)  Injuries or traumas Exposure to chemical products Side effects of certain medicines (beta blockers)  Etc. Symptoms and diagnosis There are some very frequent symptoms encountered in Raynaud’s disease patients but each patient can experience different symptoms. The fingers and toes turn white, then blue – generally after having been exposed to cold air or cold objects, or after having suffered stress – and then turn red when warmed up again. In serious cases, sores develop at the ends of the fingers or toes. In rare cases the fingers or toes can become infected or gangrenous, requiring amputation in the absence of treatment.  How to diagnose Raynaud’s disease ? Patients in our medical clinic are initially assessed by a rheumatologist and, depending on the severity, they can also be examined by a vascular specialist.  A large part of the diagnosis will focus on assessing the symptoms. In addition to a complete medical history and a medical examination, our team will generally order at least one type of blood test. A patient may also undergo a cold provocation test to highlight the colour changes in the hands or feet. With secondary Raynaud’s disease it is also important to identify - and treat- the underlying autoimmune disease that may be at the origin of the Raynaud’s disease (for example systemic sclerodermia: see the Erasmus Hospital’s systemic sclerodermia reference centre).  An examination by capillaroscopy is carried out. This non-invasive and painless examination makes it possible to visualise the capillaries in the nail bed. In the case of secondary Raynaud’s disease, as in the case of systemic sclerodermia, a reduction in the number of capillaries is observed as well as  the presence of dilated capillaries.       Treatment After an in-depth evaluation the team of doctors will draw up a treatment plan based on the type and extent of the disease, the general health status of the patient and the patient’s preferences.   Although there is no cure for Raynaud’s disease, it can normally be managed with appropriate treatment, such as:  Lifestyle changes: Limit exposure to the cold by dressing warmly: gloves, socks, scarf, hat and several layers  Stop smoking to improve circulation and your health in general Avoid the use of vibrating tools. Medical treatment Alpha blockers suppress the response of the sympathetic nervous system that leads to vasoconstriction (narrowing of the blood vessels)  Other medicines improve the blood flow to the fingers and toes by dilating the blood vessels. These include  calcium channel inhibitors and phosphodiesterase  inhibitors. Avoid using beta blockers, generally used for treating high blood pressure and that slow the heart rate and reduce the blood flow to extremities For patients who do not show a sufficient response to the aforementioned medicines there can be experimental medicine options - medicines that can be used in clinical trials. 
Raynaud’s disease
Rich page
Red Blood Cell Day 2025
On Thursday 20 February 2025, the ‘Red Blood Cell’ group of the Belgian Haematology Society and the H.U.B. are organising the next Red Blood Cell Day. Discover the programme and the speakers.  Program & speakers This event will take place at the Jules Bordet Institute, Rue Meylemeersch 90, 1070 Anderlecht, in the Tagnon Auditorium, 1st FloorSession for healthcare professionals09h00Eosinophils and SCD : Bad couple ?S. Karimi (HUB - Brussels)09h30Sickle Cell NephropathyV. Labarque (KUL - Leuven)10h00Vaccination in SCD - What is a realistic approach ?M. Hoyoux (CHU Liège - Citadelle)10h30Coffee Break 10h50Immunological and Practical Aspects of Transfusion in HemoglobinopathiesV. Deneys (CUSL - UCL - Brussels)11h20Transfusional Optimization in Transfusion-Dependent ThalassemiaG. De Luna  (Henri Mondor -APHP - Paris)11h50HSCT in Hbpathies : New regimens versus new therapiesF. Bernaudin (CHIC - Paris)12h20Cerebrovascular workup in SCDB. Biemond (UMC - Amsterdam)13h00Lunch 14h00Diagnostic pitfalls and New Therapies in RBC EnzymopathiesF. Galacteros (Henri Mondor -APHP - Paris)14h30Clinical reesearch in remote region - Experience in DRCB. Mbiya (Centre Mashi - Mbujimayi)15h00Systemic racism vs Care : A sickle cell perspectiveM. Shema (UMF lasi)15h30Pain at Home - Evolution of pain after hospital dischargeL. Vinguetama-Périanagom (ULB - Brussels)16h00Alternatives to opioïd analgesiaC. Greco (Necker-Enfants Malades - APHP - Paris)16h30Coffee Break Session for patients16h45Non-opioid analgesicsS. Hatton (Necker-Enfants Malades - APHP - Paris)17h15NutritionV. Hannecart (HUB - Brussels) & K. Egberts DrepaCoach17h45Access to healthcare and the stay or return of sick peopleS. Jassogne & K. Vanhees - Medimmigrant asbl18h45End of the event  Inscription - Professionnels de santé Inscription - Patients En collaboration avec